Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | metabotropic glutamate receptor 5 | 0.0337 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.014 | 0.2606 | 0.2606 |
Schistosoma mansoni | metabotropic glutamate receptor 2 3 (mglur group 2) | 0.0311 | 0.9035 | 1 |
Plasmodium vivax | gamma-glutamylcysteine synthetase, putative | 0.0118 | 0.1796 | 0.5 |
Brugia malayi | glutamate--cysteine ligase | 0.0118 | 0.1796 | 0.2355 |
Loa Loa (eye worm) | hypothetical protein | 0.0102 | 0.1183 | 0.1183 |
Trypanosoma cruzi | gamma-glutamylcysteine synthetase, putative | 0.0118 | 0.1796 | 0.5 |
Schistosoma mansoni | glutamate-cysteine ligase | 0.0118 | 0.1796 | 0.0939 |
Loa Loa (eye worm) | glutamate receptor | 0.0274 | 0.7629 | 0.7629 |
Plasmodium falciparum | gamma-glutamylcysteine synthetase | 0.0118 | 0.1796 | 0.5 |
Schistosoma mansoni | metabotropic glutamate receptor | 0.0229 | 0.5964 | 0.6156 |
Echinococcus multilocularis | n acetylated alpha linked acidic dipeptidase 2 | 0.015 | 0.298 | 0.1443 |
Schistosoma mansoni | metabotropic glutamate receptor | 0.0134 | 0.2371 | 0.1658 |
Toxoplasma gondii | glutamate-cysteine ligase, catalytic subunit domain-containing protein | 0.0118 | 0.1796 | 0.5 |
Loa Loa (eye worm) | glutamate receptor | 0.0108 | 0.1406 | 0.1406 |
Leishmania major | gamma-glutamylcysteine synthetase, putative | 0.0118 | 0.1796 | 0.5 |
Brugia malayi | metabotropic glutamate receptor type 2 | 0.0134 | 0.2371 | 0.3107 |
Loa Loa (eye worm) | hypothetical protein | 0.0153 | 0.3117 | 0.3117 |
Loa Loa (eye worm) | glutamate-cysteine ligase | 0.0118 | 0.1796 | 0.1796 |
Echinococcus multilocularis | metabotropic glutamate receptor 2 | 0.0229 | 0.5964 | 0.508 |
Giardia lamblia | Glutamate-cysteine ligase | 0.0118 | 0.1796 | 0.5 |
Trypanosoma brucei | gamma-glutamylcysteine synthetase | 0.0118 | 0.1796 | 0.5 |
Echinococcus granulosus | metabotropic glutamate receptor 2 | 0.0229 | 0.5964 | 0.508 |
Trypanosoma cruzi | gamma-glutamylcysteine synthetase, putative | 0.0118 | 0.1796 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0337 | 1 | 1 |
Brugia malayi | Metabotropic glutamate receptor precursor. | 0.0274 | 0.7629 | 1 |
Brugia malayi | metabotropic glutamate receptor subtype 5a (mGluR5a), putative | 0.0248 | 0.6665 | 0.8736 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | Inhibition of CRM1-mediated nucleocytoplasmic transport of RevM5 mutant in HEK293 cells assessed as RevM5-GFP nuclear localization at 0.08 ug/ml after 2 hrs by fluorescence microscopy | ChEMBL. | 18835718 | |
Activity (binding) | Inhibition of CRM1-mediated nucleocytoplasmic transport of RevM5 mutant in HEK293 cells assessed as RevM5-GFP nuclear localization at 0.4 ug/ml after 2 hrs by fluorescence microscopy | ChEMBL. | 18835718 | |
Activity (binding) | Inhibition of CRM1-mediated nucleocytoplasmic transport of RevM5 mutant in HEK293 cells assessed as RevM5-GFP nuclear localization at 2 ug/ml after 2 hrs by fluorescence microscopy | ChEMBL. | 18835718 | |
Activity (binding) | Inhibition of CRM1-mediated nucleocytoplasmic transport of RevM5 mutant in HEK293 cells assessed as RevM5-GFP nuclear localization at 10 ug/ml after 2 hrs by fluorescence microscopy | ChEMBL. | 18835718 | |
Kd (binding) | = 1850 uM | Binding affinity to human RPA70N assessed as inhibition of interaction with FITC-Ahx-DFTADDLEELDTLAS-NH2 after 1 hr by fluorescence polarization anisotropy assay | ChEMBL. | 23914285 |
Kd (binding) | = 1850 uM | Binding affinity to RPA70N (1 to 120) site1 (unknown origin) expressed in Escherichia coli BL21-DE3 cells by NMR spectroscopy | ChEMBL. | 24147804 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
3 literature references were collected for this gene.